Viral Load

"Viral Load" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.

Descriptor ID	D019562
MeSH Number(s)	E01.370.225.875.950 E05.200.875.950 G06.920.850
Concept/Terms	Viral Load Viral Load Load, Viral Viral Burden Burden, Viral Virus Titer Virus Titer Titer, Virus

Below are MeSH descriptors whose meaning is more general than "Viral Load".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Microbiological Techniques [E01.370.225.875]
Viral Load [E01.370.225.875.950]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Microbiological Techniques [E05.200.875]
Viral Load [E05.200.875.950]
Biological Sciences [G]
Microbiological Phenomena [G06]
Virus Physiological Phenomena [G06.920]
Viral Load [G06.920.850]

Below are MeSH descriptors whose meaning is more specific than "Viral Load".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Viral Load" by people in this website by year, and whether "Viral Load" was a major or minor topic of these publications.

Bar chart showing 221 publications over 26 distinct years, with a maximum of 20 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	2	2
2002	0	2	2
2003	1	5	6
2004	2	7	9
2005	0	7	7
2006	1	7	8
2007	0	12	12
2008	0	7	7
2009	0	5	5
2010	1	4	5
2011	1	7	8
2012	2	12	14
2013	1	7	8
2014	0	13	13
2015	2	8	10
2016	2	4	6
2017	5	9	14
2018	1	10	11
2019	3	9	12
2020	3	13	16
2021	4	16	20
2022	0	6	6
2023	0	2	2
2024	5	3	8
2025	2	7	9
2026	0	1	1

Below are the most recent publications written about "Viral Load" by people in Profiles.

Premeaux TA, Yeung ST, Johnson SD, Moar P, Byrareddy SN, Ndhlovu LC. Altered distribution of tissue galectins correlates with mucosal dysregulation in SIV infection. J Immunol. 2026 Jan 21; 215(1).

View in: PubMed
Ndhlovu LC, Giron LB, Galinskas J, Premeaux TA, Pang APS, Dias D, de Almeida Baptista MV, Shytaj IL, Maricato JT, Ferreira PRA, Gosuen G, Corley MJ, Friday CM, Bowler SA, Della Libera E, Sucupira MC, Hunter JR, Janini LM, Schechter M, Savarino A, Diaz RS. Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV. J Infect Dis. 2025 Nov 14; 232(5):1067-1077.

View in: PubMed
Nawfal ES, Gray A, Ladner R, Li T, Sheehan DM, Fennie K, Jean-Gilles M, Ward MK, Fernandez SB, Beach MC, D?vieux JG, Trepka MJ. Race- and ethnicity-specific patient-provider relationship characteristics associated with antiretroviral therapy adherence and viral suppression among minority women with HIV, Miami-Dade County, Florida, 2021-2022. AIDS Care. 2025 Nov; 37(11):1843-1856.

View in: PubMed
Rouzier V, Reif LK, Riche RC, Bajo MJ, Hilaire G, Devieux JG, Bang H, Abrams EJ, Deschamps MM, Schackman BR, Pape JW, Fitzgerald DW, McNairy ML. FANMI ("My Family"): A Randomized Trial of Community Cohort Care for Adolescent Girls and Young Women Living with HIV in Haiti. AIDS Behav. 2025 Dec; 29(12):3894-3907.

View in: PubMed
Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum LK, Waickman A, Shangguan S, Paquin-Proulx D, Creegan M, Bose M, Machmach K, McGraw A, Narahari A, Currier JR, Sacdalan C, Phanuphak N, Apps R, Corley M, Ndhlovu LC, Slike B, Krebs SJ, Anonworanich J, Tovanabutra S, Robb ML, Eller MA, Laird GM, Cyktor J, Daar ES, Crowell TA, Mellors JW, Vasan S, Michael NL, Kirchhoff F, Thomas R. Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts. Nat Commun. 2025 May 29; 16(1):4975.

View in: PubMed
Chavez JV, Davis Ewart L, Ilyas O, Ghanooni D, Diaz JE, Atkins L, Ramos R, Hernandez A, Stewart A, Horovath KJ, Hirshfield S, Carrico AW. 'I was like, this is gonna hurt': Implementing self-sampling of dried blood spots to measure HIV viral load. PLoS One. 2025; 20(5):e0322740.

View in: PubMed
Mounzer K, Slim J, Ramgopal M, Hedgcock M, Bloch M, Santana J, Mendes I, Guo Y, Arora P, Montezuma-Rusca JM, Sklar P, Baeten JM, Segal-Maurer S. Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex HIV Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1). Clin Infect Dis. 2025 Apr 30; 80(4):881-888.

View in: PubMed
Nawfal ES, Sheehan DM, Iba?ez GE, Hayes T, Gray A, Trepka MJ. Modeling the Mediating Effects of HIV-Related Stigma on the Associations Between Race/Ethnicity and Antiretroviral Therapy Adherence and Viral Suppression Among Diverse Racial and Ethnic Minority Women with HIV. AIDS Behav. 2025 Aug; 29(8):2530-2541.

View in: PubMed
Walker WE, Garcia LF, Palermo PM, Hakim N, Goswami DG, Dwivedi AK, Watts DM. Interferon Regulatory Factor 3 Exacerbates the Severity of COVID-19 in Mice. Crit Care Explor. 2025 Mar; 7(3):e1225.

View in: PubMed
Cyrus E, Okeke DA, Lavia O, Trepka MJ, Maragh-Bass A, Duthely L, Sciauodone M, Edwards J. A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago. HIV Res Clin Pract. 2025 Dec; 26(1):2443886.

View in: PubMed

People

Explore

Similar Concepts

Top Journals